BioSpace News Archive

Subscribe to Manufacturing Brief!

Get a weekly update including our take on the most critical issues impacting manufacturing.

June 12, 2025

Government

CDC

June 12, 2025

Hiring collage showing HR checking applicant information

Job Trends

Hiring Outlook: Indiana, California Top 2 Hot Spots for Jobs in May

The biopharma job market failed to turn around in May, but employers were still hiring, especially in Indiana and California, based on BioSpace data. The two states had the most job postings live on BioSpace last month, with Indiana showing a 108% year-over-year increase.

June 12, 2025

·

4 min read

·

Angela Gabriel

Pictured: Front view of the CDC museum in Georgia

Government

Amid ACIP Shake-Up, CDC Reinstates Hundreds of Fired Employees

The rehired staff, who number around 460, work with the CDC’s viral disease prevention efforts and sexual health testing labs, among others. The reinstatements are a ray of light in an acrimonious week that also saw protests and the complete overhaul of the agency’s vaccine advisory committee.

June 12, 2025

·

2 min read

·

Tristan Manalac

Vaccines

As New CDC Vaccine Advisors Gear Up for First Meeting, Experts Ask, ‘Where’s Cassidy?’

Scientists and analysts express concern that the newly appointed ACIP members—which include known anti-vaxxers—could relitigate recommendations that have already been made. Many are imploring Sen. Bill Cassidy to step up.

June 12, 2025

·

4 min read

·

Heather McKenzie

Big fish eats small, takeover of the company. Art collage.

Mergers & acquisitions

BioNTech Swallows Vaccine Rival CureVac in $1.25B All-Stock Acquisition

BioNTech will get CureVac’s early-stage cancer assets, including its mRNA-based glioblastoma therapy currently in Phase I development. CureVac had previously sued BioNTech for copyright infringement related to mRNA vaccine technology.

June 12, 2025

·

3 min read

·

Tristan Manalac

Isolated hand photo on yellow background. Pink hand collage style. Bright pop art template with space for text. Creative minimalistic backdrop.

Lung cancer

Nuvation Scores First FDA Nod With Oral Lung Cancer Drug

Nuvation Bio’s first approved product is Ibtrozi, a CNS-active ROS1 inhibitor that in pivotal studies showed high rates of treatment response in patients with non-small cell lung cancer.

June 12, 2025

·

2 min read

·

Tristan Manalac